Response to Antiretroviral Therapy among Patients Exposed to Three Classes of Antiretrovirals: Results from the Eurosida Study

Schlomo Staszewski(National Institute of Allergy and Infectious Diseases), Andrew Phillips(Wake Forest University), Thérèse Staub(Centre Hospitalier de Luxembourg), J-P Viard, Philippe Vanhems(Université Claude Bernard Lyon 1), Anders Blaxhult(The Royal Free Hospital), Christine Katlama(Université Paris Cité), Francisco Antunes(University of Lisbon), Ole Kirk(University of Copenhagen), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Clive Loveday(Middlesex Hospital), Nina Friis‐Møller(University of Copenhagen), Veronica Miller(University of California, Berkeley), Robert Colebunders(University of Antwerp), Peter Skinhøj(Copenhagen University Hospital), H Rozsypal, Bernard Hirschel(University of Geneva), T Saint-Marc(Hôpital Edouard Herriot), Birgit Thorup Røge(Rigshospitalet), Christian Pradier(Université Côte d'Azur), Bernadette Sommereijns, Stefano Vella, Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Jan van Lunzen(Universidade Federal de São Paulo), Thomas Benfield(University of Copenhagen), Ladislav Machala, Terese L. Katzenstein, Margaret Johnson(Duke University), Jens Nielsen(Statens Serum Institut), C Pedersen(Sennheiser (Germany)), Jan Gerstoft, Bruno Ledergerber(University Hospital of Zurich), Andrzéj Horban(Medical University of Warsaw), Nathan Clumeck(Centre Hospitalier Universitaire de Saint-Pierre), M. Dietrich(Bernhard Nocht Institute for Tropical Medicine), C. Manegold(Eppendorf (Germany)), P. Hermans(University of Liverpool), AN Phillips(The Royal Free Hospital), Cynthia Riviere(Hôpital Necker-Enfants Malades), Peter Reiss(Amsterdam Institute for Global Health and Development), N Vetter(Centers for Disease Control and Prevention)
Antiviral Therapy
January 1, 2002
Cited by 46


Related Papers